摘要:
A pharmaceutical compound of formula (I) in which R?1 and R2¿ are each hydrogen, halo, cyano or methyl, the dotted line represents an optional double bond, X is (1) or (2), Y is (3) or (4) where R?4 and R5¿ are each hydrogen, C¿1-6? alkyl, cyclopropyl or cyclopropyl-C1-6 alkyl, n is 0 or 1, and R?3 is -SR6, -SOR6, -SO¿2R?6, -COR6, -CH¿2OH or -CONHR7, where R6 is C¿1-6? alkyl and R?7¿ is hydrogen or C¿1-6? alkyl; provided that when one of R?1 and R2¿ is hydrogen and the other is fluoro, X is (1), Y is (4), R?4 and R5¿ are each hydrogen or C¿1-6? alkyl, and n is 0, then R?3¿ is not -COR6 or -CONHR7; and salts thereof.
摘要:
A pharmaceutical compound of formula (I) in which R?1 and R2¿ are each hydrogen, halo, cyano or methyl, the dotted line represents an optional double bond, X is (1) or (2), Y is (3) or (4) where R?4 and R5¿ are each hydrogen, C¿1-6? alkyl, cyclopropyl or cyclopropyl-C1-6 alkyl, n is 0 or 1, and R?3 is -SR6, -SOR6, -SO¿2R?6, -COR6, -CH¿2OH or -CONHR7, where R6 is C¿1-6? alkyl and R?7¿ is hydrogen or C¿1-6? alkyl; provided that when one of R?1 and R2¿ is hydrogen and the other is fluoro, X is (1), Y is (4), R?4 and R5¿ are each hydrogen or C¿1-6? alkyl, and n is 0, then R?3¿ is not -COR6 or -CONHR7; and salts thereof.
摘要:
The present invention provides compounds of formula (I) where n, R1, R2, R3, R4, R5 and Heteroaryl are defined herein. The compounds are inhibitors of the uptake of one or more monoamines selected from serotonin, norepinephrine and dopamine and, as such, may be useful in the treatment of disorders of the central and/or peripheral nervous system.
摘要:
The present invention provides compounds of formula (I) where n, R1, R2, R3, R4, R5 and Heteroaryl are defined herein. The compounds are inhibitors of the uptake of one or more monoamines selected from serotonin, norepinephrine and dopamine and, as such, may be useful in the treatment of disorders of the central and/or peripheral nervous system.